Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Corrigendum to "Sustainability of measles, rubella, and congenital rubella syndrome (CRS) elimination in the United States, January 2022 - June 2024" [Vaccine 46C (2025) 126681].

Vaccine·2025

Same author

Sustainability of measles, rubella, and congenital rubella syndrome (CRS) elimination in the United States, January 2022 - June 2024.

Vaccine·2025

Same author

Elimination of cervical cancer: Lessons learned from polio and earlier eradication programs.

Preventive medicine·2021

Same author

An opportunity to incentivize innovation to increase vaccine safety in the United States by improving vaccine delivery using vaccine patches.

Vaccine·2020

Same author

Adherence to Timely Vaccinations in the United States.

Pediatrics·2020

Same author

Performance of the United States Vaccine Injury Compensation Program (VICP): 1988-2019.

Vaccine·2020

Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026

Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026

Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026

Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026

Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026

Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 18, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

Measles and rubella eradication.

Alan R Hinman¹

¹Center for Vaccine Equity, Task Force for Global Health, 325 Swanton Way, Decatur, GA 30030, USA.

|November 30, 2017

Summary

This summary is machine-generated.

Measles and rubella eradication is achievable and necessary. Strengthening immunization services and surveillance is crucial for success, requiring additional resources and a target date.

Keywords:

Eradication Measles Rubella Vaccination policy

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Feb 18, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Area of Science:

Public Health
Epidemiology
Infectious Disease Control

Background:

Measles and rubella pose significant global health challenges.
Current public health programs face issues in vertical and horizontal approaches.
Congenital Rubella Syndrome (CRS) is a preventable consequence of rubella infection.

Purpose of the Study:

To discuss the feasibility and necessity of measles and rubella eradication.
To identify challenges in current public health strategies for infectious disease control.
To outline the requirements for achieving global eradication goals.

Main Methods:

Review of eradication concepts and public health program structures.
Analysis of current issues and challenges in measles and rubella control.
Discussion of strategies for strengthening immunization and surveillance systems.

Main Results:

Measles and rubella, including CRS, can be eradicated globally.
Eradication requires a concerted effort beyond current program limitations.
A defined target date is essential for focused eradication efforts.

Conclusions:

Global eradication of measles and rubella is a viable and urgent public health objective.
Strengthening routine immunization services and robust disease surveillance are fundamental prerequisites.
Achievement necessitates increased resource allocation and a commitment to established timelines.